ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.740
+0.180 (5.06%)
Jun 18, 2026, 11:28 AM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.54 billion as of June 17, 2026. Its market cap has decreased by -61.90% in one year.
Market Cap
1.54B
Enterprise Value
657.83M
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.74
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.54B, a decrease of -78.92%. That is a compound annual growth rate of -42.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.57B | -37.56% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 2.04B |
| Frontage Holdings | 1.99B |
| SinoMab BioScience | 1.79B |
| HighTide Therapeutics | 1.63B |
| Mabpharm | 1.59B |
| Zhaoke Ophthalmology | 1.57B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.26B |
| Kintor Pharmaceutical | 1.19B |